Everton, Janaína B. F.; Patrício, Fernando J. B.; Faria, Manuel S.; Ferreira, Teresa Cristina Alves; Romão, Elen Almeida 
; Silva, Gyl Eanes Barros ; Magalhães, Marcelo
Source: European Journal of Clinical Pharmacology. Unidade: FMRP
Subjects: FARMACOCINÉTICA, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EVERTON, Janaína B. F. et al. CYP3A5 and PPARA genetic variants are associated with low trough concentration to dose ratio of tacrolimus in kidney transplant recipients. European Journal of Clinical Pharmacology, v. 77, n. 6, p. 879-886, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00228-020-03076-8. Acesso em: 27 nov. 2025.APA
Everton, J. B. F., Patrício, F. J. B., Faria, M. S., Ferreira, T. C. A., Romão, E. A., Silva, G. E. B., & Magalhães, M. (2021). CYP3A5 and PPARA genetic variants are associated with low trough concentration to dose ratio of tacrolimus in kidney transplant recipients. European Journal of Clinical Pharmacology, 77( 6), 879-886. doi:10.1007/s00228-020-03076-8NLM
Everton JBF, Patrício FJB, Faria MS, Ferreira TCA, Romão EA, Silva GEB, Magalhães M. CYP3A5 and PPARA genetic variants are associated with low trough concentration to dose ratio of tacrolimus in kidney transplant recipients [Internet]. European Journal of Clinical Pharmacology. 2021 ; 77( 6): 879-886.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s00228-020-03076-8Vancouver
Everton JBF, Patrício FJB, Faria MS, Ferreira TCA, Romão EA, Silva GEB, Magalhães M. CYP3A5 and PPARA genetic variants are associated with low trough concentration to dose ratio of tacrolimus in kidney transplant recipients [Internet]. European Journal of Clinical Pharmacology. 2021 ; 77( 6): 879-886.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1007/s00228-020-03076-8
